| Date | Title | Description | |
|---|---|---|---|
| 23 Jul 2026 | On P&L | The Company releases the press release related to the first half of 2026 financial results | Download |
| 23 Jul 2026 | On P&L | The Company releases the first half 2026 financial results presentation | Download |
| 06 May 2026 | On P&L | The Company releases the press release related to the first three months of 2026 financial results. | Download |
| 06 May 2026 | On P&L | The Company releases the first three months of 2026 financial results presentation. | Download |
| 25 Feb 2026 | On P&L | The Company releases the press release related to the full year 2025 financial results. | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 03 Nov 2021 | On business and financial situation | The Company releases the first nine months 2021 financial results presentation | Download |
| 03 Nov 2021 | On business and financial situation | The Company releases the press release related to the first nine months 2021 financial results | Download |
| 21 Oct 2021 | Liquidity and counterparty agreements | Download | |
| 21 Oct 2021 | On business and financial situation | The Company informs of the delay in the decision on Risperidone ISM® by the U.S. Food and Drug Administration (“FDA”). | Download |
| 07 Oct 2021 | Liquidity and counterparty agreements | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 26 Feb 2019 | Información sobre resultados | ROVI releases the presentation related to the full year 2018 results | Download |
| 26 Feb 2019 | Información sobre resultados | ROVI releases the press release related to the full year 2018 results | Download |
| 15 Feb 2019 | Others on business performance and financial information | ROVI acquires rights to Dexchlorpheniramine Maleate in the Spanish and French markets | Download |
| 09 Jan 2019 | Others on business performance and financial information | ROVI informs about the adquisition of Falithrom® for the German market | Download |
| 08 Jan 2019 | Liquidity contracts and specialists | Liquidity contract: transactions conducted in the fourth quarter of 2018 | Download |